Edition:
United Kingdom

Innoviva Inc (INVA.OQ)

INVA.OQ on NASDAQ Stock Exchange Global Select Market

15.42USD
8:11pm BST
Change (% chg)

$0.03 (+0.19%)
Prev Close
$15.39
Open
$15.31
Day's High
$15.51
Day's Low
$15.27
Volume
91,723
Avg. Vol
240,102
52-wk High
$17.98
52-wk Low
$11.47

Chart for

About

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium... (more)

Overall

Beta: 2.58
Market Cap(Mil.): $1,566.05
Shares Outstanding(Mil.): 109.36
Dividend: --
Yield (%): --

Financials

  INVA.OQ Industry Sector
P/E (TTM): 20.00 30.92 33.69
EPS (TTM): 0.72 -- --
ROI: 26.11 14.76 14.30
ROE: -- 16.26 16.03

BRIEF-Innoviva Reports Q1 Adjusted Earnings Per Share $0.35

* Q1 EARNINGS PER SHARE VIEW $0.53 -- THOMSON REUTERS I/B/E/S

26 Apr 2018

Earnings vs. Estimates